Evidence map›Paper›PMID 15957002›Full record

ArticleEuropean journal of human genetics : EJHG2005

Communication of pharmacogenetic research results to HIV-infected treated patients: standpoints of professionals and patients.

Grégoire Moutel, Nathalie Duchange, François Raffi, Lama I Sharara, Ioannis Théodorou, Violaine Noël, Sandrine de Montgolfier, Ingrid Callies, François Bricaire, Christian Hervé and 2 more

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Observational
  4. Article
  5. Communication of genetic test results to family and health-care providers following disclosure of research results.Genetics in medicine : official journal of the American College of Medical Genetics · 2014
    Article
  6. Article
  7. Article
  8. Feedback of trial results to participants: a survey of clinicians' and patients' attitudes and experiences.European journal of oncology nursing : the official journal of European Oncology Nursing Society · 2011
    Article
  9. Article
  10. Article
  11. Researcher practices on returning genetic research results.Genetic testing and molecular biomarkers · 2010
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Grégoire MoutelLaboratoire d'Ethique Médicale et Médecine Légale & Institut International de Recherche en Ethique Biomédicale, Faculté de Médecine Paris 5. 45 rue des Saints-Pères, Paris 75006, France. moutel@necker.fr
Nathalie Duchange
François Raffi
Lama I Sharara
Ioannis Théodorou
Violaine Noël
Sandrine de Montgolfier
Ingrid Callies
François Bricaire
Christian Hervé
Catherine Leport
APROCO-COPILOTE Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of pharmacogenetic studies is to adapt therapeutic strategies to individual genetic profiles, thus maximising their efficacy and minimising the likelihood of adverse side effects. Since the advent of personalised medicine, the issue of communicating research results to participants has become increasingly important. We addressed this question in the context of HIV infection, as patients and associations are particularly concerned by research and therapeutic advances. We explored the standpoints of both research professionals and participants involved in a pharmacogenetic study conducted in a cohort of HIV-infected patients. The setting of the research protocol was followed over a 2-year period. Participants' standpoints were collected through a questionnaire and interviews were conducted with research professionals. Of 125 participants, 76% wished to receive individual results and 71% wished to receive collective results; 39% did not know when results might be expected. Communication of global research results is a principle that is generally accepted by professionals. Concerning individual feedback, the professionals felt that it was necessary if it could be of direct benefit to the participant, but they expressed doubts for situations with no recognised benefit. Our results highlight the necessity to consider this issue in greater detail. We suggest the need to anticipate the debates concerning individual feedback, to differentiate between situations and the importance of further investigations on the opportunities and modalities of communication. Finally, our work emphasised the opposite pressures between the pursuit of scientific knowledge and the therapeutic orientation of clinical trials.

Indexed as

Attitude of Health PersonnelAttitude to HealthCommunicationGenetic ResearchHIV InfectionsControlled Clinical Trials as TopicEthics, MedicalHumansInformed ConsentInterviews as TopicPharmacogeneticsPhysician-Patient RelationsSurveys and Questionnaires

Identifiers

PMID15957002
PMCPMC1868604

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.